The store will not work correctly when cookies are disabled.
3-(4-(pyridin-3-yl)phenyl)-1-(pyrrolidin-1-yl)propan-1-one
ID: ALA4576952
PubChem CID: 155554152
Max Phase: Preclinical
Molecular Formula: C18H20N2O
Molecular Weight: 280.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCc1ccc(-c2cccnc2)cc1)N1CCCC1
Standard InChI: InChI=1S/C18H20N2O/c21-18(20-12-1-2-13-20)10-7-15-5-8-16(9-6-15)17-4-3-11-19-14-17/h3-6,8-9,11,14H,1-2,7,10,12-13H2
Standard InChI Key: LGUYHZSWVQYXES-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
18.6878 -8.3793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9733 -7.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2589 -8.3793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5444 -7.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8299 -8.3793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5444 -7.1417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0728 -8.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5207 -8.6552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9333 -9.3697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7402 -9.1981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6849 -9.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3984 -9.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1139 -9.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1113 -8.3759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3970 -7.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8279 -9.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8276 -10.4428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5418 -10.8543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2567 -10.4408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2530 -9.6115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5382 -9.2038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
4 6 2 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 5 1 0
1 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 1 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
13 16 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.37 | Molecular Weight (Monoisotopic): 280.1576 | AlogP: 3.30 | #Rotatable Bonds: 4 |
Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.73 | CX LogP: 2.53 | CX LogD: 2.53 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.86 | Np Likeness Score: -1.10 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |